These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 2921098

  • 1. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.
    Leclercq V, Harvengt C.
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):76-81. PubMed ID: 2921098
    [Abstract] [Full Text] [Related]

  • 2. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E, Kreisberg R, Miller V, Mantell G, Washington L, Shapiro DR.
    Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M, Bonnefous F, Debbas N, Irvine A.
    Arch Intern Med; 1994 Feb 28; 154(4):441-9. PubMed ID: 8117177
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia].
    Darioli R, Bovet P, Brunner HR, Bercher L.
    Schweiz Med Wochenschr; 1990 Jan 27; 120(4):85-91. PubMed ID: 2305221
    [Abstract] [Full Text] [Related]

  • 5. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989 Jan 27; 11(2):247-57. PubMed ID: 2736571
    [Abstract] [Full Text] [Related]

  • 6. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin].
    Brocard JJ, Keller U, Oberhänsli A, Riesen WF.
    Schweiz Med Wochenschr; 1991 Jun 29; 121(26):977-83. PubMed ID: 1862314
    [Abstract] [Full Text] [Related]

  • 7. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.
    Lambert M, Lupien PJ, Gagné C, Lévy E, Blaichman S, Langlois S, Hayden M, Rose V, Clarke JT, Wolfe BM, Clarson C, Parsons H, Stephure DK, Potvin D, Lambert J.
    Pediatrics; 1996 May 29; 97(5):619-28. PubMed ID: 8628597
    [Abstract] [Full Text] [Related]

  • 8. Beneficial effect of simvastatin in patients with drug resistant familial hypercholesterolaemia.
    Lewis-Barned NJ, Ball MJ.
    N Z Med J; 1992 Jul 22; 105(938):284-6. PubMed ID: 1495661
    [Abstract] [Full Text] [Related]

  • 9. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 Jul 22; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 10. Fish oil supplementation in patients with heterozygous familial hypercholesterolemia.
    Balestrieri GP, Maffi V, Sleiman I, Spandrio S, Di Stefano O, Salvi A, Scalvini T.
    Recenti Prog Med; 1996 Mar 22; 87(3):102-5. PubMed ID: 8650428
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia.
    Marnini P, Colombo F, Cattaneo R, Geroli L, Venco A.
    Int J Clin Pharmacol Res; 1992 Mar 22; 12(2):65-70. PubMed ID: 1428300
    [Abstract] [Full Text] [Related]

  • 12. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.
    Mol MJ, Stuyt PM, Demacker PN, Stalenhoef AF.
    Neth J Med; 1990 Apr 22; 36(3-4):182-90. PubMed ID: 2355995
    [Abstract] [Full Text] [Related]

  • 13. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O, Pancallo MT, Della Valle M, Marasco A, Malarbi AL.
    Clin Ter; 1991 Jun 15; 137(5):333-7. PubMed ID: 1832606
    [Abstract] [Full Text] [Related]

  • 14. [Simvastatin in the treatment of familial hypercholesterolemia].
    Ceska R, Sobra J, Procházková R, Kvasilová M.
    Cas Lek Cesk; 1995 May 17; 134(10):310-3. PubMed ID: 7788650
    [Abstract] [Full Text] [Related]

  • 15. [Effects of simvastatin on atherogenic blood lipid pattern].
    Alessandri C, Peverini F, Basili S, Barsi R, Paradiso M, Marotta P, Censi C, Cordova C, Balsano F.
    Recenti Prog Med; 1991 Apr 17; 82(4):225-9. PubMed ID: 1857842
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G.
    Can J Cardiol; 1993 Jun 17; 9(5):405-12. PubMed ID: 8348392
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
    Clauss SB, Holmes KW, Hopkins P, Stein E, Cho M, Tate A, Johnson-Levonas AO, Kwiterovich PO.
    Pediatrics; 2005 Sep 17; 116(3):682-8. PubMed ID: 16140708
    [Abstract] [Full Text] [Related]

  • 18. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
    Geisel J, Oette K, Burrichter H.
    Fortschr Med; 1990 Feb 10; 108(4):71-2, 75-6. PubMed ID: 2312032
    [Abstract] [Full Text] [Related]

  • 19. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr 10; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]

  • 20. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin and the human lens. Clinical results of a 3-year follow-up.
    Behrens-Baumann W, Thiery J, Wieland E, Fieseler HG, Seidel D.
    Arzneimittelforschung; 1992 Aug 10; 42(8):1023-4. PubMed ID: 1418074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.